Turkish scientists Ugur Sahin founding partner where biontech and the vaccine virus to the corona developed by German Pfizer, including OraTau resulting Turkey and the UK spanning more than 60 countries revealed to be effective against the B117 mutations.
The results are based on a blood analysis of the trial participants, based on a more comprehensive analysis than those published by the US drug manufacturer last week.
Pfizer announced earlier last week that a similar laboratory study showed why the vaccine was highly infectious, showing that it was effective against a key mutation in the spike protein N501Y.
The last study, which has not yet been reviewed by the reviewer, was conducted on 10 mutations occurring in the variant known as B117, identified in England.
Please Fill In Your Information Fully, We Will Reach You As Soon As Possible
You can share any opinion, suggestion or complaint about our Medical Center with us via this form. You can be sure that we will store your information with precision and take necessary actions immediately.